We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Comparative study of weekly and three-weekly neoadjuvant carboplatin in triple-negative breast cancer: retrospective analysis in real-world settings

    Purpose

    Tri-weekly carboplatin is an established neoadjuvant treatment for triple-negative breast cancer, enhancing pathological complete response...

    Ana Isabel Martin-Quesada, Elisenda Llabres-Valentí, ... Isaac Núñez-Hernández in Clinical and Translational Oncology
    Article 21 March 2024
  2. Twice-Weekly Versus Once-Weekly Membrane Swee** in the Prevention of Post-Term Pregnancy: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Membrane swee** is considered a simple and effective method for initiating spontaneous onset of labor. Despite the widely accepted membrane...

    Saeed Baradwan, Majed Saeed Alshahrani, ... Suzan Elsharkawy in Reproductive Sciences
    Article 27 July 2023
  3. Twice weekly dosing with Sebelipase alfa (Kanuma®) rescues severely ill infants with Wolman disease

    Background

    Sebelipase alfa (Kanuma®) is approved for patients with Wolman disease (WD) at a dosage of 3–5 mg/kg once weekly. Survival rates in the...

    María José de Castro, Simon A Jones, ... Arunabha Ghosh in Orphanet Journal of Rare Diseases
    Article Open access 25 June 2024
  4. Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy

    Background

    For patients with locally advanced nasopharyngeal cancer (LA-NPC), concurrent chemoradiotherapy (CCRT) is the standardized treatment....

    **n Li, Lei Li, ... Wei **ong in European Journal of Medical Research
    Article Open access 05 October 2023
  5. Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes

    Despite the availability of new classes of glucose-lowering drugs that improve glycaemic levels and minimise long-term complications, at least 20–25%...

    Roberto Trevisan, Matteo Conti, Stefano Ciardullo in Diabetologia
    Article Open access 29 April 2024
  6. Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis

    Background

    Physical and emotional symptoms are prevalent in patients with kidney-dysfunction requiring dialysis (KDRD) and the rigors of thrice-weekly...

    Mariana Murea, Benjamin R. Highland, ... Gregory B. Russell in BMC Nephrology
    Article Open access 27 September 2022
  7. The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China

    Background

    To estimate the long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin as an add-on therapy for type 2 diabetes...

    Shuyan Gu, **ghong Gu, ... Biao Xu in Health Economics Review
    Article Open access 02 April 2024
  8. Do sociodemographic risk profiles for adolescents engaging in weekly e-cigarette, cigarette, and dual product use differ?

    Background

    E-cigarette use represents a contemporary mode of nicotine product use that may be changing the risk profile of participating adolescents....

    Katelyn Battista, Karen A Patte, ... Scott T Leatherdale in BMC Public Health
    Article Open access 10 June 2024
  9. Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis

    Background

    Randomized controlled trials have found that once-weekly insulin resulted in greater glycemic control compared to once-daily insulin in...

    Peng Wang, Yu Zhang, ... Fang Fang in Diabetology & Metabolic Syndrome
    Article Open access 03 January 2024
  10. Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma

    Background

    Tri-weekly cisplatin and radiotherapy (CDDP + RT) is a standard of care for locally advanced head and neck squamous cell carcinoma...

    Yusuke Uchinami, Koichi Yasuda, ... Hidefumi Aoyama in Discover Oncology
    Article Open access 08 December 2023
  11. Impact of thrice-weekly cotrimoxazole prophylaxis on creatinine and potassium plasma levels in kidney transplant recipients

    Introduction

    Cotrimoxazole (CTX) 800/160 mg daily or thrice-weekly is recommended as prophylaxis of Pneumocystis jirovecii pneumonia in kidney...

    August Ardhe, Arnaud Devresse, ... Michel Jadoul in Journal of Nephrology
    Article 16 September 2023
  12. Timeliness and completeness of weekly surveillance data reporting on epidemic prone diseases in Uganda, 2020–2021

    Introduction

    Disease surveillance provides vital data for disease prevention and control programs. Incomplete and untimely data are common challenges...

    Hildah Tendo Nansikombi, Benon Kwesiga, ... Emma S. Arinaitwe in BMC Public Health
    Article Open access 04 April 2023
  13. Twice or thrice weekly levothyroxine provides similar rates of adherence and post-Ramadan euthyroidism compared to daily levothyroxine during Ramadan fasting

    Background

    Having to take levothyroxine (L-T4) on a daily basis, on an empty stomach is burdensome and may impair adherence, especially during Ramadan...

    Tamer Mohamed Elsherbiny in Thyroid Research
    Article Open access 06 December 2023
  14. Efficacy of Self-Review of Lifestyle Behaviors with Once-Weekly Glycated Albumin Measurement in People with Type 2 Diabetes: A Randomized Pilot Study

    Introduction

    Lifestyle management, including appropriate modifications of nutrition, exercise, and medication behaviors, is essential for optimal...

    Hideaki **nouchi, Akira Yoshida, ... Koshin Sekimizu in Diabetes Therapy
    Article Open access 16 May 2024
  15. Weekly minutes of moderate to vigorous physical activity is associated with movement quality in overweight and obese older adults, independent of age

    Background

    Physical activity can improve function and decrease healthcare spending among overweight and obese older adults. Although unstructured...

    Julie Rekant, April Chambers, ... Jen Brach in Aging Clinical and Experimental Research
    Article 20 October 2023
  16. Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study

    Introduction

    Type 2 diabetes is a prevalent condition. The change in glucose control and body weight with the use of once-weekly semaglutide was...

    Dagoberto Serpa-Díaz, Carlos A. Llanos-Florez, ... Maria A. Alzate-Vinasco in Diabetes Therapy
    Article Open access 30 April 2024
  17. A propensity score–weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer

    Purpose

    A 4-weekly schedule of pegylated liposomal doxorubicin (PLD) has been approved for the treatment of metastatic breast cancer (MBC). Phase II...

    H. Bischoff, C. Bigot, ... P. Trensz in Breast Cancer Research and Treatment
    Article 23 December 2022
  18. Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial

    Background

    The approved dose of Selinexor, 60 mg twice-weekly, is associated with several clinically relevant toxicities. Preclinical studies show...

    Abdulazeez Salawu, Eoghan R. Malone, ... Albiruni R. Abdul Razak in Targeted Oncology
    Article 19 June 2024
  19. Intermittent theta-burst stimulation combined with transcranial direct current stimulation once weekly for treatment-resistant depression: a case report

    Background

    Single-time non-invasive brain stimulation was carried out using the two-technique approach on a patient suffering from treatment-resistant...

    Pakorn Wivatvongvana, Chutimon Soonthornthum, Kittipong Kitisak in Journal of Medical Case Reports
    Article Open access 02 October 2023
  20. Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma

    Background

    The optimal chemotherapy regimen in concurrent chemoradiotherapy (CCRT) for cisplatin-ineligible head and neck squamous cell carcinoma...

    Yushi Ueki, Shusuke Ohshima, ... Arata Horii in International Journal of Clinical Oncology
    Article 16 October 2023
Did you find what you were looking for? Share feedback.